COMPASS THERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Jun 2018 | $-7.9K | $-7.9K | — | — |
| Sep 2018 | $-4.8K | $-4.8K | — | — |
| Dec 2018 | $-10.3K | $-10.3K | — | — |
| Mar 2020 | $-7.8M | $-7.8M | $12.0K | $247.0K |
| Jun 2020 | $-5.3M | $-5.3M | $4.0K | — |
| Sep 2020 | $-7.2M | $-7.2M | $7.0K | — |
| Mar 2021 | $-5.6M | $-5.7M | $128.0K | $948.0K |
| Jun 2021 | $-5.9M | — | $296.0K | — |
| Sep 2021 | $-3.5M | $-3.8M | $367.0K | — |
| Mar 2022 | $-7.9M | $-8.1M | $194.0K | $1.6M |
| Jun 2022 | $-4.6M | $-4.5M | $-63.0K | — |
| Sep 2022 | $-10.9M | $-11.0M | $27.0K | — |
| Mar 2023 | $-12.2M | $-12.2M | $0 | $1.3M |
| Jun 2023 | $-10.1M | $-10.1M | $11.0K | — |
| Sep 2023 | $-5.9M | $-5.9M | $10.0K | — |
| Mar 2024 | $-13.9M | $-13.9M | $0 | $2.0M |
| Jun 2024 | $-10.8M | $-10.8M | $0 | — |
| Sep 2024 | $-11.1M | $-11.1M | $44.0K | — |
| Mar 2025 | $-13.2M | $-13.2M | $18.0K | $2.5M |
| Jun 2025 | $-11.8M | $-11.8M | $0 | — |
| Sep 2025 | $-10.8M | $-10.9M | $7.0K | — |
| Mar 2026 | $-17.3M | $-17.4M | $82.0K | $5.1M |
| Jun 2026 | $-14.7M | $-14.9M | $176.0K | — |